J. Torzewski

发表

Potential myogenic stem cell populations: sources, plasticity, and application for cardiac repair.

K. Myburgh, C. Niesler, E. Schabort, 2009, Stem cells and development.

Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion.

H. Gabbert, S. Bhakdi, M. Klouche, 1998, Arteriosclerosis, thrombosis, and vascular biology.

BIOSOLVE‐IV‐registry: Safety and performance of the Magmaris scaffold: 12‐month outcomes of the first cohort of 1,075 patients

B. Yan, T. Buck, M. Lee, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

C‐reactive protein specifically binds to Fcγ receptor type I on a macrophage‐like cell line

C. Röcker, G. Nienhaus, K. Tron, 2008, European journal of immunology.

On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety

S. Bhakdi, J. Tranum-Jensen, E. Wieland, 1995, The Journal of experimental medicine.

Interferon beta-1b therapy in chronic viral dilated cardiomyopathy--is there a role for specific therapy?

M. Radermacher, V. Hombach, J. Wiehe, 2010, Journal of cardiac failure.

Prognostic role of myocardial tumor necrosis factor‐alpha and terminal complement complex expression in patients with dilated cardiomyopathy

V. Hombach, T. Zwaka, M. Höher, 2007, European journal of heart failure.

Myocardial biopsy based classification and treatment in patients with dilated cardiomyopathy.

V. Hombach, T. Zwaka, P. Lepper, 2005, International journal of cardiology.

Myocardial biopsy findings and gadolinium enhanced cardiovascular magnetic resonance in dilated cardiomyopathy

V. Hombach, N. Merkle, J. Torzewski, 2006, European journal of heart failure.

GMP-adapted overexpression of CXCR4 in human mesenchymal stem cells for cardiac repair.

W. Rottbauer, J. Wöhrle, N. Fekete, 2013, International journal of cardiology.

Critical Role for Monocyte Chemoattractant Protein-1 and Macrophage Inflammatory Protein-1α in Induction of Experimental Autoimmune Myocarditis and Effective Anti–Monocyte Chemoattractant Protein-1 Gene Therapy

H. Katus, T. Dengler, K. Egashira, 2005, Circulation.

In-hospital results of transcatheter aortic valve implantation (TAVI) in a district hospital--an approach to treat TAVI patients in rural areas.

N. Doll, M. Karch, Zhongmin Liu, 2013, International journal of cardiology.

C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries.

W. Koenig, V. Hombach, J. Waltenberger, 1998, Arteriosclerosis, thrombosis, and vascular biology.

Selective C‐Reactive Protein‐Apheresis in Patients

C. Garlichs, A. Sheriff, J. Torzewski, 2019, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

The terminal complement complex inhibits apoptosis in vascular smooth muscle cells by activating an autocrine IGF‐1 loop

A. Hoeflich, V. Hombach, T. Zwaka, 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Immunohistochemical colocalization of the terminal complex of human complement and smooth muscle cell alpha-actin in early atherosclerotic lesions.

V. Hombach, H. Gabbert, J. Waltenberger, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Complement-induced release of monocyte chemotactic protein-1 from human smooth muscle cells. A possible initiating event in atherosclerotic lesion formation.

P. Lachmann, D. Proudfoot, J. Torzewski, 1996, Arteriosclerosis, thrombosis, and vascular biology.

No difference in 30-day outcome and quality of life in transradial versus transfemoral access - Results from the German Austrian ABSORB registry (GABI-R).

S. Achenbach, J. Mehilli, T. Riemer, 2021, Cardiovascular revascularization medicine : including molecular interventions.

Two year efficacy and safety of small versus large ABSORB bioresorbable vascular scaffolds of ≤18 mm device length: A subgroup analysis of the German-Austrian ABSORB RegIstRy (GABI-R)

C. Hamm, J. Wöhrle, J. Torzewski, 2020, International journal of cardiology. Heart & vasculature.

The resorbable magnesium scaffold Magmaris in acute coronary syndrome: An appraisal of evidence and user group guidance.

M. Sabaté, E. Cerrato, A. Ielasi, 2021, Cardiovascular revascularization medicine : including molecular interventions.

Successful Use of mRNA-Nucleofection for Overexpression of Interleukin-10 in Murine Monocytes/Macrophages for Anti-inflammatory Therapy in a Murine Model of Autoimmune Myocarditis

W. Rottbauer, H. Katus, G. Pfitzer, 2012, Journal of the American Heart Association.

Efficient transient genetic labeling of human CD34+ progenitor cells for in vivo application.

K. Schwarz, H. Döhner, V. Hombach, 2006, Regenerative medicine.

Intima of Early Atherosclerotic Lesions of Human Coronary Arteries C-Reactive Protein Frequently Colocalizes With the Terminal Complement Complex in the

W. Koenig, V. Hombach, J. Waltenberger, 1998 .

Cardiac involvement in a female carrier of Duchenne muscular dystrophy.

V. Hombach, A. Sperfeld, C. Burgstahler, 2010, International journal of cardiology.

Safety and performance of a resorbable magnesium scaffold under real-world conditions: 12-month outcomes of the first 400 patients enrolled in the BIOSOLVE-IV registry.

T. Buck, M. Lee, R. J. van der Schaaf, 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Prognostic significance of magnetic resonance imaging parameters in patients with idiopathic dilated cardiomyopathy

V. Rasche, V. Hombach, N. Merkle, 2009, Journal of Cardiovascular Magnetic Resonance.

Inhibition of human arterial smooth muscle cell growth by human monocyte/macrophages: a co-culture study.

D. Proudfoot, J. Torzewski, D. Bowyer, 1999, Atherosclerosis.

mRNA-Mediated Gene Delivery Into Human Progenitor Cells Promotes Highly Efficient Protein Expression

V. Hombach, M. Rojewski, H. Schrezenmeier, 2007, Journal of cellular and molecular medicine.

C-Reactive Protein–Mediated Low Density Lipoprotein Uptake by Macrophages: Implications for Atherosclerosis

V. Hombach, Vinzenz Hombach, J. Torzewski, 2001, Circulation.

“First in Man”: Case Report of Selective C-Reactive Protein Apheresis in a Patient with Acute ST Segment Elevation Myocardial Infarction

C. Garlichs, A. Sheriff, J. Torzewski, 2018, Case reports in cardiology.

Author reply to letter from J. Smedema

V. Hombach, N. Merkle, J. Torzewski, 2006 .

Monday, 27 August 2012

V. V. Ivanenko, E. A. Medvedeva, Michail I. Papafaklis, 2012 .

Cardiac glycosides potently inhibit C-reactive protein synthesis in human hepatocytes.

P. Kolkhof, A. Geerts, J. Torzewski, 2010, Biochemical and biophysical research communications.

Affinity of C-reactive protein toward FcgammaRI is strongly enhanced by the gamma-chain.

G Ulrich Nienhaus, C. Röcker, G. Nienhaus, 2007, The American journal of pathology.

Labeling of adult stem cells for in vivo-application in the human heart.

V. Hombach, J. Wiehe, J. Torzewski, 2005, Histology and histopathology.

Transient Genetic Labeling of Human CD34-Positive Hematopoietic Stem Cells Using Nucleofection

K. Schwarz, H. Döhner, V. Hombach, 2004, Transfusion Medicine and Hemotherapy.

C-Reactive Protein in the Arterial Intima: Role of C-Reactive Protein Receptor–Dependent Monocyte Recruitment in Atherogenesis

W. Koenig, V. Hombach, T. Zwaka, 2000, Arteriosclerosis, thrombosis, and vascular biology.

C-reactive protein and atherogenesis: new insights from established animal models.

J. Torzewski, 2005, The American journal of pathology.

Complement and dilated cardiomyopathy: a role of sublytic terminal complement complex-induced tumor necrosis factor-alpha synthesis in cardiac myocytes.

V. Hombach, T. Zwaka, N. Marx, 2002, The American journal of pathology.

Processes in atherogenesis: complement activation.

J. Waltenberger, J. Torzewski, D. Bowyer, 1997, Atherosclerosis.

Interleukin-1beta stimulates acute phase response and C-reactive protein synthesis by inducing an NFkappaB- and C/EBPbeta-dependent autocrine interleukin-6 loop.

V. Hombach, Y. Ivashchenko, J. Torzewski, 2008, Molecular immunology.

C-Reactive Protein in Human Atherogenesis: Facts and Fiction

Zhongmin Liu, J. Torzewski, K. Li, 2014, Mediators of inflammation.

Pentameric C-reactive protein dissociation on microparticles following myocardial infarction and in the pathogenesis of Alzheimer ’ s disease

H. Schunkert, Tag der Mündlichen, J. Torzewski, 2014 .

Diagnostic performance of magnetic resonance first pass perfusion imaging is equally potent in female compared to male patients with coronary artery disease

V. Hombach, J. Wöhrle, N. Merkle, 2009, Clinical Research in Cardiology.

Protein Kinase C Pathway Is Involved in Transcriptional Regulation of C-Reactive Protein Synthesis in Human Hepatocytes

V. Hombach, A. Busch, Y. Ivashchenko, 2004, Arteriosclerosis, thrombosis, and vascular biology.

Synthesis in Human Hepatocytes Protein Kinase C Pathway Is Involved in Transcriptional Regulation of C-Reactive Protein

V. Hombach, A. Busch, Y. Ivashchenko, 2004 .

Targeting C-Reactive Protein by Selective Apheresis in Humans: Pros and Cons

P. Brunner, C. Garlichs, A. Sheriff, 2022, Journal of clinical medicine.

Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy

H. Kestler, V. Hombach, J. Kraus, 2009, European heart journal.

Myocardial inflammation and non-ischaemic heart failure: is there a role for C-reactive protein?

V. Hombach, V. Mailänder, J. Torzewski, 2009, Basic Research in Cardiology.

Inhibiting C-Reactive Protein Synthesis by Cardiac Glycosides in Humans

J. Torzewski, O. Zimmermann, M. Zaczkiewicz, 2016 .

Cardiac Glycosides Lower C-Reactive Protein Plasma Levels in Patients with Decompensated Heart Failure: Results from the Single-Center C-Reactive Protein-Digoxin Observational Study (C-DOS)

J. Torzewski, B. Mayer, O. Zimmermann, 2022, Journal of clinical medicine.

C-reactive protein and atherosclerosis. Is there a causal link?

W. Koenig, V. Hombach, J. Torzewski, 2003, Histology and histopathology.

Characterization of patients with acute chest pain using cardiac magnetic resonance imaging

H. Kestler, V. Rasche, V. Hombach, 2008, Clinical Research in Cardiology.

Serum Starvation and Growth Factor Receptor Expression in Vascular Smooth Muscle Cells

A. Hannekum, V. Hombach, T. Zwaka, 2006, Journal of Vascular Research.

Safety and performance of the third-generation drug-eluting resorbable coronary magnesium scaffold system in the treatment of subjects with de novo coronary artery lesions: 6-month results of the prospective, multicenter BIOMAG-I first-in-human study

M. Joner, J. Escaned, R. Waksman, 2023, EClinicalMedicine.

Ultrasensitive Confocal Fluorescence Microscopy of C-Reactive Protein Interacting With Fc&ggr;RIIa

V. Hombach, C. Röcker, G. Nienhaus, 2004, Arteriosclerosis, thrombosis, and vascular biology.

C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis

V. Hombach, T. Zwaka, J. Torzewski, 2001 .

Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial

G. Stone, S. Ellis, S. Marx, 2018, The Lancet.

A Report on the First 7 Sequential Patients Treated Within the C-Reactive Protein Apheresis in COVID (CACOV) Registry

A. Sheriff, J. Torzewski, F. Heigl, 2021, The American journal of case reports.

Successful Treatment of a 39-Year-Old COVID-19 Patient with Respiratory Failure by Selective C-Reactive Protein Apheresis

A. Sheriff, J. Torzewski, Stefan Kayser, 2021, The American journal of case reports.

First-in-Man: Case Report of Selective C-Reactive Protein Apheresis in a Patient with SARS-CoV-2 Infection

C. Schumann, A. Sheriff, J. Torzewski, 2020, The American journal of case reports.

C-Reactive Protein Apheresis as Anti-inflammatory Therapy in Acute Myocardial Infarction: Results of the CAMI-1 Study

P. Nordbeck, H. Darius, S. Mitzner, 2021, Frontiers in Cardiovascular Medicine.

Imaging Predictors of Left Ventricular Functional Recovery after Reperfusion Therapy of ST-Elevation Myocardial Infarction Assessed by Cardiac Magnetic Resonance

P. Nordbeck, A. Schuster, H. Darius, 2023, Journal of cardiovascular development and disease.

Implications for Atherosclerosis Mediated Low Density Lipoprotein Uptake by Macrophages : − C-Reactive Protein

V. Hombach, T. Zwaka, J. Torzewski, 2001 .

One- and two-year clinical outcomes of treatment with resorbable magnesium scaffolds for coronary artery disease: the prospective, international, multicentre BIOSOLVE-IV registry.

T. Buck, S. Verheye, M. Moccetti, 2023, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Large diverticulum of the urinary bladder: A rare cause of deep vein thrombosis with consecutive pulmonary embolism.

J. Torzewski, O. Zimmermann, E. Reichenbach-Klinke, 2015, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Sustainability of C-Reactive Protein Apheresis in Acute Myocardial Infarction—Results from a Supplementary Data Analysis of the Exploratory C-Reactive Protein in Acute Myocardial Infarction-1 Study

R. Kunze, C. Garlichs, H. Skarabis, 2022, Journal of Clinical Medicine.

On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety

S. Bhakdi, E. Wieland, J. Torzewski, 1995, The Journal of experimental medicine.

Immunohistochemical Demonstration of Enzymatically Modified Human LDL and Its Colocalization With the Terminal Complement Complex in the Early Atherosclerotic Lesion

H. Gabbert, S. Bhakdi, M. Klouche, 1998 .

Large diverticulum of the urinary bladder: A rare cause of deep vein thrombosis with consecutive pulmonary embolism.

J. Torzewski, O. Zimmermann, E. Reichenbach-Klinke, 2015, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Road Map to Drug Discovery and Development–Inhibiting C-reactive protein for the Treatment of Cardiovascular Disease

J. Torzewski, K. Li, O. Zimmermann, 2011 .

Vascular Biology, Atherosclerosis and Endothelium Biology Affinity of C-Reactive Protein toward Fc (cid:1) RI Is Strongly Enhanced by the (cid:1) -Chain

G. Nienhaus, K. Tron, J. Torzewski, 2007 .

Potential myogenic stem cell populations: sources, plasticity, and application for cardiac repair.

K. Myburgh, C. Niesler, E. Schabort, 2009, Stem cells and development.

Five-Year Clinical Outcomes After Coronary Bioresorbable Scaffolds and Drug-Eluting Stents: The ABSORB IV Randomized Trial.

J. Spertus, G. Stone, S. Marx, 2023, Journal of the American College of Cardiology.

A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-1 first-in-human study.

M. Joner, J. Escaned, R. J. van der Schaaf, 2023, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

The Analysis of microRNA Expression Profiling for Coronary Artery Disease

Zhongmin Liu, Qinchuan Li, J. Torzewski, 2013, Cardiology.